Award-winning litigation The firm recently earned the 2026 Elite Trial Lawyers award in Antitrust from The National Law Journal, signaling strong recognition in high-stakes complex litigation. This prestige presents an opportunity to approach enterprise clients seeking proven antitrust capabilities and high-profile trial experience.

Antitrust specialization With demonstrated success in antitrust matters such as Innovative Health LLC v. Biosense Webster, the firm positions itself as a go-to resource for clients facing regulatory or competitive challenges. Target potential clients in health tech, medical devices, and healthcare sectors needing robust antitrust defense or private enforcement support.

Trial and appellate depth The firm emphasizes complex trial and appellate litigation across the United States for both plaintiffs and defendants. This breadth suggests opportunities with mid-market to large corporate clients needing versatile litigation teams able to handle appeals, complex motions, and high-stakes disputes.

Strong revenue but lean Reported revenue is in the $50M–$100M range with a relatively small team (201–500 employees) compared to large firms. This indicates efficiency and a potential selling point for clients seeking experienced, cost-conscious litigators capable of delivering big-law results with a boutique feel.

Strategic growth prospects Recent hires and continued awards visibility suggest the firm is expanding its capabilities and brand. Business development efforts could target clients expanding litigation footprints, require bespoke appellate strategy, or seek proven trial teams for complex, cross-border or multi-jurisdictional matters.